Subcutaneous injections are a widely used method for drug delivery. One of its major drawbacks is the pain inflicted during the process. Sindolor has developed the chemical-free EZ-Ject Injector device, based on employing cutaneous local anesthesia on the injection site by an electronic anesthetic system. The purpose of this study is to determine the safety and efficacy of the EZ-Ject for subcutaneous injections.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
SINGLE
Enrollment
42
EZ-Ject Injector device employee cutaneous local anesthesia on the injection site by an electronic anesthetic system
Ichilov Medical center
Tel Aviv, Israel
Study primary goal is to evaluate the safety of using the EZ-Ject Injector device for subcutaneous injections.The safety of using the EZ-Ject Injector device will be established by paucity of major complications that are device-related.
Time frame: immediately
Study secondary goal is to asses the efficacy of using the EZ-Ject Injector device. Efficacy will be assessed by alleviating injection pain. Subjective discomfort and pain will be assessed by analogue pain scale (VAS Scale).
Time frame: immediately
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.